Robert G. Kilbourn

5.5k total citations · 3 hit papers
53 papers, 4.2k citations indexed

About

Robert G. Kilbourn is a scholar working on Physiology, Biochemistry and Surgery. According to data from OpenAlex, Robert G. Kilbourn has authored 53 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Physiology, 15 papers in Biochemistry and 11 papers in Surgery. Recurrent topics in Robert G. Kilbourn's work include Nitric Oxide and Endothelin Effects (32 papers), Eicosanoids and Hypertension Pharmacology (15 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Robert G. Kilbourn is often cited by papers focused on Nitric Oxide and Endothelin Effects (32 papers), Eicosanoids and Hypertension Pharmacology (15 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Robert G. Kilbourn collaborates with scholars based in United States, Spain and Netherlands. Robert G. Kilbourn's co-authors include Owen W. Griffith, Roberto Levi, Paula Belloni, Steven S. Gross, Robert F. Lodato, Amal Jubran, Avishay Sella, Jerry M. Adams, R. J. Amato and Eric Jaffe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Robert G. Kilbourn

53 papers receiving 4.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.

1990 520 citations Robert G. Kilbourn, Steven S. Gross et al. profile →
A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.

1990 463 citations C. Logothetis, F. H. Dexeus et al. profile →
Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis

1990 455 citations Robert G. Kilbourn, Amal Jubran et al. Biochemical and Biophysical Research Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert G. Kilbourn United States	27	2.0k	1.0k	869	719	583	53	4.2k
Ronald Curran United States	24	2.3k 1.1×	573 0.6×	1.2k 1.4×	709 1.0×	602 1.0×	46	4.1k
M. Johan Broekman United States	44	704 0.3×	636 0.6×	571 0.7×	1.2k 1.7×	681 1.2×	79	5.2k
H Nawata Japan	34	1.1k 0.5×	1.0k 1.0×	231 0.3×	1.5k 2.1×	428 0.7×	173	5.1k
Nobutaka Inoue Japan	44	1.8k 0.9×	832 0.8×	492 0.6×	1.5k 2.1×	1.4k 2.5×	106	5.5k
Mauricio Di Silvio United States	20	1.9k 0.9×	450 0.4×	879 1.0×	773 1.1×	516 0.9×	46	3.3k
Timothy R. Billiar United States	23	1.4k 0.7×	586 0.6×	435 0.5×	1.2k 1.7×	601 1.0×	32	3.4k
D J Hanahan United States	34	900 0.4×	604 0.6×	522 0.6×	1.5k 2.1×	829 1.4×	58	4.5k
S Bunting United States	27	1.3k 0.7×	1.2k 1.2×	1.2k 1.4×	2.4k 3.4×	438 0.8×	52	7.3k
Pierré Sirois Canada	38	2.8k 1.4×	483 0.5×	460 0.5×	1.5k 2.1×	956 1.6×	310	6.2k
Rosemary A. Hoffman United States	31	1.1k 0.5×	943 0.9×	322 0.4×	869 1.2×	1.6k 2.7×	101	4.0k

Countries citing papers authored by Robert G. Kilbourn

Since Specialization

Citations

This map shows the geographic impact of Robert G. Kilbourn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert G. Kilbourn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert G. Kilbourn more than expected).

Fields of papers citing papers by Robert G. Kilbourn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert G. Kilbourn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert G. Kilbourn. The network helps show where Robert G. Kilbourn may publish in the future.

Co-authorship network of co-authors of Robert G. Kilbourn

This figure shows the co-authorship network connecting the top 25 collaborators of Robert G. Kilbourn. A scholar is included among the top collaborators of Robert G. Kilbourn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert G. Kilbourn. Robert G. Kilbourn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kilbourn, Robert G., et al.. (2009). DESIGN AND CONSTRUCTION OF A SCANNING TUNNELING MICROSCOPE FOR ATOMIC SCALE IMAGING OF SURFACES IN ULTRA-HIGH VACUUM. Bulletin of the American Physical Society. 1 indexed citations

Doursout, Marie–Françoise, Robert G. Kilbourn, Craig J. Hartley, & Jacques E. Chelly. (2000). Effects of N-methyl-L-arginine on cardiac and regional blood flow in a dog endotoxin shock model. Journal of Critical Care. 15(1). 22–29. 14 indexed citations

Shahidi, Homayoun & Robert G. Kilbourn. (1998). The role of nitric oxide in interleukin-2 therapy induced hypotension. Cancer and Metastasis Reviews. 17(1). 119–126. 7 indexed citations

Kilbourn, Robert G.. (1998). The Discovery of Nitric Oxide as a Key Mediator in Septic Shock. 1(2). 85–91. 20 indexed citations

Evans, Gregory R. D., Giulio Gherardini, Ali Gürlek, et al.. (1997). Drug-Induced Vasodilation in an in Vitro and in Vivo Study: The Effects of Nicardipine, Papaverine, and Lidocaine on the Rabbit Carotid Artery. Plastic & Reconstructive Surgery. 100(6). 1475–1481. 48 indexed citations

Kilbourn, Robert G., Daniel L. Traber, & Csaba Szabó. (1997). Nitric oxide and shock. Disease-a-Month. 43(5). 279–348. 62 indexed citations

Griffith, Owen W. & Robert G. Kilbourn. (1997). Design of nitric oxide synthase inhibitors and their use to reverse hypotension associated with cancer immunotherapy. Advances in Enzyme Regulation. 37. 171–194. 12 indexed citations

Griffith, Owen W. & Robert G. Kilbourn. (1996). Nitric oxide synthase inhibitors: Amino acids. Methods in enzymology on CD-ROM/Methods in enzymology. 268. 375–392. 100 indexed citations

Gross, Steven S., Robert G. Kilbourn, & Owen W. Griffith. (1996). NO in septic shock: Good, bad or ugly? Learning from iNOS knockouts. Trends in Microbiology. 4(2). 47–49. 23 indexed citations

10.

Kilbourn, Robert G.. (1996). Nitric oxide: moving towards the clinic. Molecular Medicine Today. 2(8). 324–324. 3 indexed citations

11.

Joly, Ghislaine A., et al.. (1995). Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta. British Journal of Pharmacology. 115(3). 491–497. 12 indexed citations

12.

Aggarwal, Bharat B., et al.. (1995). Phase I Study of Tumor Necrosis Factor Plus Actinomycin D in Patients with Androgenindependent Prostate Cancer. PubMed. 10(3). 225–235. 11 indexed citations

13.

Krishnaswamy, Narayanan, Kirk McMillan, Robert G. Kilbourn, et al.. (1995). S-Alkyl-l-thiocitrullines. Journal of Biological Chemistry. 270(19). 11103–11110. 72 indexed citations

14.

Amato, R. J., Christina Meyers, Julie A. Ellerhorst, et al.. (1995). A phase I trial of intermittent high-dose α-interferon and dexamethasone in metastatic renal cell carcinoma. Annals of Oncology. 6(9). 911–914. 18 indexed citations

15.

Joly, Ghislaine A., et al.. (1994). Effects of NG-Methyl-L-arginine, NG-Nitro-L-arginine, and Aminoguanidine on Constitutive and Inducible Nitric Oxide Synthase in Rat Aorta. Biochemical and Biophysical Research Communications. 199(1). 147–154. 129 indexed citations

16.

Sella, Avishay, Robert G. Kilbourn, Laury Finn, et al.. (1994). Phase I Study of Interleukin-2 Combined with Interferon-α and 5-Fluorouracil in Patients with Metastatic Renal Cell Cancer. PubMed. 9(2). 103–111. 25 indexed citations

17.

Kilbourn, Robert G.. (1991). Regulation of nitric oxide biosynthesis: cofactor requirement and enzymatic characteristics. Research in Immunology. 142(7). 587–588. 1 indexed citations

18.

Dexeus, Francisco H., et al.. (1991). Combination Chemotherapy with Methotrexate, Bleomycin and Cisplatin for Advanced Squamous Cell Carcinoma of the Male Genital Tract. The Journal of Urology. 146(5). 1284–1287. 86 indexed citations

19.

Logothetis, Christopher J., F. H. Dexeus, Avishay Sella, et al.. (1990). Escalated Therapy for Refractory Urothelial Tumors: Methotrexate- Vinblastine-Doxorubicin- Cisplatin Plus Unglycosylated Recombinant Human Granulocyte-macrophage Colony-Stimulating Factor. JNCI Journal of the National Cancer Institute. 82(8). 667–672. 86 indexed citations

20.

Kilbourn, Robert G., Amal Jubran, Steven S. Gross, et al.. (1990). Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochemical and Biophysical Research Communications. 172(3). 1132–1138. 455 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact